BIIB Earnings

Quarterly EPS
$2.67
Q3 2024
$1.83
Q4 2024
$1.65
Q1 2025
$4.33
Q2 2025
$3.18
Q3 2025
$-0.33
Q4 2025
$2.17
Q1 2026
$0.66
Q2 2026
Latest Revenue2.7B
Latest Net Income97.5M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.662.7B97.5M+3.4%-84.8%
Q1 2026$2.172.5B319.5M+1.9%+31.5%
Q4 2025-$0.332.3B-48900000-7.1%-118.0%
Q3 2025$3.182.5B466.5M+2.8%+19.1%
Q2 2025$4.332.6B634.8M+7.3%+8.0%
Q1 2025$1.652.4B240.5M+6.1%-39.1%
Q4 2024$1.832.5B266.7M+2.9%+6.4%
Q3 2024$2.672.5B388.5M-2.5%+668.1%
Q2 2024$4.012.5B583.6M
Q1 2024$2.712.3B393.4M
Q4 2023$1.722.4B248.9M
Q3 2023-$0.472.5B-68300000
Biogen (BIIB) — Earnings